More than $730 million was recovered in fiscal year 2023 as a result of several state agencies’ coordinated efforts to audit and investigate complaints of fraud, waste, and abuse in the Texas Medicaid program.
The recently released Joint Annual Interagency Coordination Report for fiscal year 20231 details the efforts of the Texas Health and Human Services Office of Inspector General (OIG), the Texas Office of Attorney General Medicaid Fraud Control Unit (MFCU), and the Texas Office of Attorney General Civil Medicaid Fraud Division (CMF).
In FY2023, OIG recovered more than $532 million in Medicaid and non-Medicaid amounts; CMF recovered more than $151 million in Medicaid and non-Medicaid amounts; and MFCU recovered more than $51 million.
A CMF state civil action against Shire OLC, Baxter International, Baxalta Incorporated, Viorpharma Inc., Takeda Pharmaceuticals USA, and Takeda Pharmaceuticals America resulted in a total Texas recovery of more than $42 million. An additional total Texas recovery of $3 million was recovered from Biogen Inc. after a CMF federal/state civil action.